Unnamed: 0,title,date,stock,sentiment
769913.0,96 Biggest Movers From Friday,2020-05-11 05:14:00-04:00,LMNX,neutral
769914.0,70 Stocks Moving In Friday's Mid-Day Session,2020-05-08 12:43:00-04:00,LMNX,neutral
769915.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-05 10:48:00-04:00,LMNX,neutral
769916.0,Luminex Sees Q2 At Or Above $105M; Says Is Confident Will Beat Top End Of FY20 Current Guidance Range,2020-05-04 16:08:00-04:00,LMNX,positive
769917.0,"Luminex Q1 EPS $0.010 Beats $(0.030) Estimate, Sales $90.424M Beat $82.300M Estimate",2020-05-04 16:07:00-04:00,LMNX,neutral
769918.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-01 07:42:00-04:00,LMNX,neutral
769919.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-28 10:18:00-04:00,LMNX,neutral
769920.0,Stocks That Hit 52-Week Highs On Monday,2020-04-27 10:21:00-04:00,LMNX,neutral
769921.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-23 10:41:00-04:00,LMNX,neutral
769922.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-21 10:30:00-04:00,LMNX,neutral
769923.0,Stocks That Hit 52-Week Highs On Monday,2020-04-20 10:25:00-04:00,LMNX,neutral
769924.0,Stocks That Hit 52-Week Highs On Friday,2020-04-17 10:19:00-04:00,LMNX,neutral
769925.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-16 10:19:00-04:00,LMNX,neutral
769926.0,A Peek Into The Markets: US Stock Futures Signal Higher Wall Street Open,2020-04-07 06:01:00-04:00,LMNX,neutral
769927.0,"5 Stocks To Watch For April 7, 2020",2020-04-07 04:55:00-04:00,LMNX,neutral
769928.0,Luminex shares are trading higher after the company reported it received FDA emergency use authorization for ARIES SARS-CoV-2 assay to detect virus responsible for COVID-19 disease. The company sees Q1 sales just over $90 million vs $83.3 million est.,2020-04-06 16:44:00-04:00,LMNX,positive
769929.0,Luminex shares are trading higher after the company reported it received FDA emergency use authorization for ARIES SARS-CoV-2 assay to detect virus responsible for COVID-19 disease. The company sees Q1 sales just over $90 million vs $83.3 million est.,2020-04-06 16:44:00-04:00,LMNX,positive
769930.0,Luminex Sees Q1 Sales Just Over $90M vs $83.3M Estimate,2020-04-06 16:30:00-04:00,LMNX,neutral
769931.0,Luminex Receives FDA Emergency Use Authorization for ARIES SARS-CoV-2 Assay to Detect Virus Responsible for COVID-19 Disease,2020-04-06 07:31:00-04:00,LMNX,negative
769932.0,"Luminex Receives BARDA Contract To Support Development Of Second, Rapid Coronavirus Test",2020-03-31 07:35:00-04:00,LMNX,positive
769933.0,A Peek Into The Markets: US Stock Futures Edge Higher; Crude Oil Tumbles Over 5%,2020-03-30 06:24:00-04:00,LMNX,negative
769934.0,"5 Stocks To Watch For March 30, 2020",2020-03-30 04:50:00-04:00,LMNX,neutral
769935.0,Luminex Receives FDA Emergency Use Authorization For NxTAG CoV Extended Panel To Detect Coronavirus,2020-03-27 16:05:00-04:00,LMNX,negative
769936.0,Luminex Highlights 4 Independent Labs Report Data From Evaluation Of ARIES System For Coronavirus Test,2020-03-13 07:31:00-04:00,LMNX,neutral
769937.0,Stocks That Hit 52-Week Highs On Wednesday,2020-03-04 10:24:00-05:00,LMNX,neutral
769938.0,Luminex Corp Says Developed A Multiplex Panel That Addresses Current Coronavirus Outbreak Using Its Existing Bead-Based NXTAG Technology,2020-03-04 07:37:00-05:00,LMNX,neutral
769939.0,Stocks That Hit 52-Week Highs On Tuesday,2020-03-03 10:44:00-05:00,LMNX,neutral
769940.0,Luminex Reports Submission Of VERIGENE II Respiratory Flex Assay For FDA Clearance,2020-02-24 09:10:00-05:00,LMNX,neutral
769941.0,"Luminex Q4 EPS $0.07 Vs. $(0.01) Estimate, Sales $90.5M Miss $90.6M Estimate",2020-02-10 16:09:00-05:00,LMNX,negative
769942.0,Luminex Corporation Sees FY 2019 Revenue $334.6M vs $335.3M Est; Q4 Revenue $90.4M vs $91.22M Est,2020-01-12 17:12:00-05:00,LMNX,neutral
769943.0,Luminex Cuts FY19 Sales Guidance From $337M-$343M To $334M-$337M vs $340M Estimate,2019-11-04 15:54:00-05:00,LMNX,negative
769944.0,Luminex shares are trading lower after the company reported worse-than-expected Q3 EPS and sales results.,2019-11-04 15:51:00-05:00,LMNX,neutral
769945.0,"Luminex Q3 EPS $(0.12) Misses $(0.03) Estimate, Sales $78.673M Miss $81.76M Estimate",2019-11-04 15:47:00-05:00,LMNX,negative
769946.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-09 12:55:00-04:00,LMNX,negative
769947.0,"Benzinga's Top Upgrades, Downgrades For September 27, 2019",2019-09-27 09:39:00-04:00,LMNX,positive
769948.0,"JP Morgan Downgrades Luminex to Underweight, Lowers Price Target to $21",2019-09-27 06:32:00-04:00,LMNX,positive
769949.0,Luminex Sees Q3 Sales $80M-$83M vs $83M Estimate; Reaffirms FY19 Sales $337M-$343M vs $340.4M Est.,2019-07-31 16:02:00-04:00,LMNX,neutral
769950.0,"Luminex Q2 Adj. EPS $(0.1) Misses $(0.01) Estimate, Sales $83.056M Beat $81.7M Estimate",2019-07-31 16:01:00-04:00,LMNX,negative
769951.0,Luminex Reports Submission Of ARIES MRSA Assay For FDA Clearance,2019-07-01 16:32:00-04:00,LMNX,neutral
769952.0,EDP Biotech To Develop And Market Colorectal Cancer Early Detection Blood Test Using Luminex xMAP Technology,2019-05-28 07:09:00-04:00,LMNX,negative
769953.0,"Luminex Sees Q2 Sales $80M-$83M vs $82.38M Est., Reaffirms FY19 Sales Guidance Of $337M-$343M vs $341.44M Est.",2019-05-06 16:06:00-04:00,LMNX,neutral
769954.0,"Luminex Q1 EPS $0.07, Inline, Adj. EPS $(0.07), Sales $82.41M Miss $83.11M Estimate",2019-05-06 16:05:00-04:00,LMNX,negative
769955.0,Q1 Earnings Outlook For Luminex,2019-05-06 09:19:00-04:00,LMNX,neutral
769956.0,50 Biggest Movers From Yesterday,2019-02-06 05:03:00-05:00,LMNX,neutral
769957.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-02-05 12:35:00-05:00,LMNX,neutral
769958.0,Luminex shares are trading lower after the company reported Q4 EPS of $0.04 versus the $0.09 estimate. The company also forecast Q1 sales of $82 million-$84 million versus the $85.29M estimate.,2019-02-05 10:44:00-05:00,LMNX,neutral
769959.0,32 Stocks Moving In Tuesday's Pre-Market Session,2019-02-05 07:53:00-05:00,LMNX,neutral
769960.0,Luminex shares are trading lower after the company reported Q4 EPS of $0.04 versus the $0.09 estimate. The company also sees Q1 sales of $82M to $84M versus the $$85.29M estimate.,2019-02-04 16:55:00-05:00,LMNX,neutral
769961.0,Luminex Sees Q1 Sales $82M-$84M; FY19 Sales $337M-$343M,2019-02-04 16:14:00-05:00,LMNX,neutral
769962.0,"Luminex Q4 EPS $0.04 Misses $0.09 Estimate, Sales $81.1M Beat $78.97M Estimate",2019-02-04 16:14:00-05:00,LMNX,negative
769963.0,Luminex Corporation Grants AllerGenis Rights To Develop And Market PRecision Food Allergy Diagnostic Unit Using Th e Luminex xMAP Technology,2019-01-16 09:49:00-05:00,LMNX,positive
769964.0,Luminex Sees FY2019 Sales $337.0M-343.0M vs $333.79M Est,2019-01-07 08:25:00-05:00,LMNX,neutral
769965.0,Luminex,2019-01-07 08:24:00-05:00,LMNX,neutral
769966.0,Luminex Sees Q4 Sales $81.0M vs $78.0M Est,2019-01-07 08:23:00-05:00,LMNX,neutral
769967.0,"Stocks That Will Be Trading Ex Dividend Wed., Dec. 19, 2018",2018-12-18 11:41:00-05:00,LMNX,neutral
769968.0,75 Biggest Movers From Yesterday,2018-11-07 04:00:00-05:00,LMNX,neutral
769969.0,60 Stocks Moving In Tuesday's Mid-Day Session,2018-11-06 12:36:00-05:00,LMNX,neutral
769970.0,Luminex Sees Q4 Sales $77M-$79M vs $77.5M Estimate; FY18 Sales $310M-$316M vs $313.6M Est.,2018-11-05 16:44:00-05:00,LMNX,neutral
769971.0,"Luminex Corporation Q3 EPS $0.05, Inline, Sales $72.445M Miss $74.05M Estimate",2018-11-05 16:43:00-05:00,LMNX,negative
769972.0,Luminex Reports Purchase Of MilliporeSigma's Flow Cytometry Portfolio For $75M,2018-10-18 06:05:00-04:00,LMNX,neutral
769973.0,"Stocks Trading Ex Dividend For Thurs., Sep. 20, 2018",2018-09-20 06:25:00-04:00,LMNX,neutral
769974.0,77 Biggest Movers From Yesterday,2018-08-08 06:04:00-04:00,LMNX,neutral
769975.0,Mid-Afternoon Market Update: Commercial Vehicle Group Rises On Earnings Beat; Luminex Shares Slide,2018-08-07 14:34:00-04:00,LMNX,positive
769976.0,64 Stocks Moving In Tuesday's Mid-Day Session,2018-08-07 13:01:00-04:00,LMNX,neutral
769977.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,LMNX,neutral
769978.0,Luminex shares are trading down 22.1% after the company missed Q2 sales estimates and issued Q3 and 2018 guidance near low end of estimates.,2018-08-07 11:26:00-04:00,LMNX,negative
769979.0,Luminex Sees FY18 Sales $310M-$316M vs $314.72M Est.,2018-08-06 16:26:00-04:00,LMNX,neutral
769980.0,Luminex Sees Q3 Sales $72.5M-$74.5M vs $74.33M Est.,2018-08-06 16:25:00-04:00,LMNX,neutral
769981.0,"Luminex Q2 Adj. EPS $0.15, Inline, Sales $79.578M Miss $79.62M Estimate",2018-08-06 16:24:00-04:00,LMNX,negative
769982.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,LMNX,neutral
769983.0,"Stocks Which Set New 52-Week High Yesterday, August 2nd",2018-08-03 11:16:00-04:00,LMNX,neutral
769984.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,LMNX,neutral
769985.0,Luminex Reports Initiation Of Clinical Studies For Gastrointestinal Assay On VERIGENE II System,2018-06-13 09:02:00-04:00,LMNX,neutral
769986.0,Luminex Sees Q2 Sales $78.5M-$80M vs $79.95M Est.; FY18 Sales $310M-$316M vs $312.96M Est.,2018-05-07 16:03:00-04:00,LMNX,neutral
769987.0,"Luminex Q1 EPS $0.30 Beats $0.20 Estimate, Sales $82.7M Beat $80.47M Estimate",2018-05-07 16:02:00-04:00,LMNX,neutral
769988.0,"Benzinga's Top Upgrades, Downgrades For May 7, 2018",2018-05-07 09:20:00-04:00,LMNX,positive
769989.0,Deutsche Bank Upgrades Luminex to Hold,2018-05-07 07:41:00-04:00,LMNX,neutral
769990.0,Luminex Sees Q1 Sales $79M-$81M vs $80.79M; FY18 Sales $310M-$316M vs $310.06M Est.,2018-02-12 16:10:00-05:00,LMNX,neutral
769991.0,"Luminex Reports Q4 EPS $0.20 May Not Compare to $0.09 Est., Sales $78.199M vs $77M Est.",2018-02-12 16:10:00-05:00,LMNX,neutral
769992.0,"Luminex Saturday Announced Prelim Q4 Sales $78M vs $76.89M Est. and At Top End Of Previously Issued Guidance, FY17 Sales $306M vs $305.13M Est.",2018-01-08 09:35:00-05:00,LMNX,positive
769993.0,"BTIG Research Initiates Coverage On Luminex with Buy Rating, Announces $24.00 Price Target",2018-01-05 07:47:00-05:00,LMNX,neutral
769994.0,Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay,2017-10-31 16:05:00-04:00,LMNX,neutral
769995.0,Luminex Reaffirms FY17 Outlook; Sees Q4 Sales $76M-$78M vs $76.7M Est.,2017-10-30 16:09:00-04:00,LMNX,neutral
769996.0,"Luminex Reports Q3 Adj. EPS $0.25 vs $0.10 Est., Sales $74.1M vs $74.4M Est.",2017-10-30 16:08:00-04:00,LMNX,neutral
769997.0,"Luminex Reports Q2 Adj. EPS $0.26, GAAP EPS $0.13 vs $0.10 Est., Sales $76.5M vs $75.5M Est.",2017-08-07 16:15:00-04:00,LMNX,neutral
769998.0,Luminex Reports Received FDA Clearance For ARIES C. Difficile Assay,2017-07-24 08:30:00-04:00,LMNX,neutral
770003.0,Luminex Reports Received CE-IVD Mark For ARIES Norovirus Assay,2017-06-28 08:01:00-04:00,LMNX,neutral
770016.0,"Bank Of America Health Care Conference Begins Today; Presenters Include Luminex, Acadia Healthcare, Express Scripts, Puma Biotech, Ultragenyx Pharma, Alexion, Medicines Co., Juno, TherapeuticsMD, & Seattle Genetics",2017-05-16 08:32:00-04:00,LMNX,positive
770017.0,"Deutsche Bank Healthcare Conference Begins Today; Presenters Include Synergy Pharma, Exelixis, AbbVie, Collegium Pharma, Zimmer Biomet, Luminex, CRISPR Therapeutics, & Edwards Lifesciences",2017-05-03 08:22:00-04:00,LMNX,neutral
770018.0,Luminex Reports Received FDA Clearance for ARIES Bordetella Assay,2017-05-03 08:03:00-04:00,LMNX,neutral
770019.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Chegg Surges Higher,2017-05-02 14:43:00-04:00,LMNX,negative
770020.0,Luminex Sees Q2 Sales $74M-$76M vs $75M Est.,2017-05-01 16:07:00-04:00,LMNX,neutral
770021.0,Luminex Raises FY17 Sales Outlook from $295M-$305M to $300M-$310M vs $301.3M Est.,2017-05-01 16:07:00-04:00,LMNX,neutral
770022.0,"Luminex Reports Q1 Adj EPS $0.28 May Not Compare to $0.07 Est., Sales $77.8M vs $74.2M Est.",2017-05-01 16:06:00-04:00,LMNX,neutral
770023.0,Luminex Corporation Announces Initiation of Quarter Cash Dividend Of $0.06/Share,2017-02-21 16:14:00-05:00,LMNX,neutral
770024.0,"Luminex Sees Q1 Rev. $73-$75M vs. Est. $74M, FY17 Rev. $295-$305M vs. Est. $299M",2017-02-06 16:08:00-05:00,LMNX,neutral
770025.0,"Luminex Reports Q4 EPS $0.11 vs. Est. $0.09, Rev. $72.3M vs. Est. $70.9M",2017-02-06 16:07:00-05:00,LMNX,neutral
770026.0,Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector,2017-01-18 12:29:00-05:00,LMNX,positive
770027.0,"Deutsche Bank Initiates Coverage On Luminex At Sell, Announces $18 Price Target",2017-01-18 08:40:00-05:00,LMNX,neutral
770028.0,Deutsche Bank Initiates Coverage on Medical Equipment Names,2017-01-17 17:59:00-05:00,LMNX,neutral
770029.0,Luminex Sees FY2017 Sales $295.0M-305.0M vs $293.72M Est,2017-01-09 08:34:00-05:00,LMNX,neutral
770030.0,Luminex Expecting Q4 Revenue $72M vs $70M Est,2017-01-09 08:34:00-05:00,LMNX,neutral
770031.0,Luminex Corporation Receives FDA Clearance for ARIES GBS Assay,2017-01-04 08:02:00-05:00,LMNX,neutral
770032.0,18 Biggest Mid-Day Losers For Tuesday,2016-11-01 14:17:00-04:00,LMNX,negative
770033.0,"Luminex Reports non-GAAP EPS $0.21 vs $0.10 Est, Revenue $71.2M vs $68.6M Est",2016-10-31 16:06:00-04:00,LMNX,neutral
770034.0,Benzinga's Top Initiations,2016-10-12 09:12:00-04:00,LMNX,positive
770035.0,"Avondale Partners Initiates Coverage On Luminex Corporation - Common Stock at Outperform, Announces $27.00",2016-10-12 08:37:00-04:00,LMNX,neutral
770036.0,20 Stocks Which Rallied Three Days On Increasing Volume,2016-09-23 09:19:00-04:00,LMNX,neutral
770037.0,Benzinga's Top Upgrades,2016-08-18 09:08:00-04:00,LMNX,positive
770038.0,JP Morgan Upgrades Luminex to Neutral,2016-08-18 06:17:00-04:00,LMNX,positive
770039.0,FTC Sends Warning To Online Sources Capitalizing Off Zika Fear With 'Protective' Products,2016-08-08 11:20:00-04:00,LMNX,negative
770040.0,Luminex Reports Received FDA Emergency Use Authorization for Zika Virus Moelcular Detection Assay,2016-08-08 08:32:00-04:00,LMNX,negative
770041.0,Luminex Reports FDA Clearance for ARIES Flu A/B & RSV Assay,2016-08-03 08:33:00-04:00,LMNX,negative
770042.0,"Luminex Reports Q2 EPS $0.33 Does Not Compare To  Est. $0.15, Rev. $64.1M vs. Est. $61M",2016-07-28 17:10:00-04:00,LMNX,neutral
770043.0,A Peek Into The Markets: U.S. Stock Futures Slide Ahead Of Fed Minutes,2016-07-06 07:59:00-04:00,LMNX,neutral
770044.0,Luminex Gets FDA Approval And CE-IVD Mark For Its ARIES M1 System,2016-07-06 07:57:00-04:00,LMNX,positive
770045.0,Luminex Reports Received FDA Clearance for CE-IVD Mark for ARIES M1 System,2016-07-06 07:02:00-04:00,LMNX,neutral
770046.0,Luminex Commences Acquisition of Nanosphere for $1.70/Share Cash,2016-06-02 06:04:00-04:00,LMNX,neutral
770047.0,Luminex Gets CE-IVD Mark For ARIES Flu A/B & RSV Assay,2016-06-01 11:19:00-04:00,LMNX,negative
770048.0,Luminex Corporation Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay,2016-06-01 09:16:00-04:00,LMNX,negative
770049.0,8 Biggest Mid-Day Winners,2016-05-23 13:29:00-04:00,LMNX,positive
770050.0,Mid-Morning Market Update: Markets Slightly Higher; Arbor Pharmaceuticals to Buy XenoPort For $7.03/Share,2016-05-23 10:00:00-04:00,LMNX,neutral
770051.0,The Market In 5 Minutes: Merger Monday Mania,2016-05-23 08:58:00-04:00,LMNX,neutral
770052.0,12 Stocks Moving In Monday's Pre-Market Session,2016-05-23 08:26:00-04:00,LMNX,neutral
770053.0,Luminex Sweetens Bid To Buy Nanosphere,2016-05-23 07:35:00-04:00,LMNX,neutral
770054.0,Luminex Raises Acquisition Price for Nanosphere from $1.35 to $1.70/Share; Have Entered Agreement,2016-05-23 06:02:00-04:00,LMNX,positive
770055.0,Rodman & Renshaw Downgrades Nanosphere Following Luminex Acquisition,2016-05-18 08:51:00-04:00,LMNX,neutral
770056.0,Mid-Afternoon Market Update: Dow Jumps 200 Points; Aduro Biotech Shares Drop Following Announcement of Failed Phase 2b ECLIPSE Trial,2016-05-16 14:31:00-04:00,LMNX,negative
770057.0,Mid-Day Market Update: Nanosphere Jumps Following Luminex Deal; Breitburn Energy Partners Shares Drop,2016-05-16 12:06:00-04:00,LMNX,positive
770058.0,Mid-Morning Market Update: Markets Open Higehr; Pfizer To Acquire Anacor Pharmaceuticals For $5.2B,2016-05-16 10:08:00-04:00,LMNX,neutral
770059.0,10 Stocks Moving In Monday's Pre-Market Session,2016-05-16 08:24:00-04:00,LMNX,neutral
770060.0,"Merger Monday: 6 Deals, Rumors And Bids You Might Have Missed",2016-05-16 08:13:00-04:00,LMNX,negative
770061.0,Luminex Agrees To Buy Nanosphere For $58 Million,2016-05-16 07:36:00-04:00,LMNX,positive
770062.0,Luminex to Acquire Nanosphere for $1.35/Share in Cash,2016-05-16 06:03:00-04:00,LMNX,neutral
770063.0,Luminex Sees Q2 Sales $60M-$62M vs $61.9M Est.,2016-05-02 16:34:00-04:00,LMNX,neutral
770064.0,Luminex Raises Lower End of FY16 Sales Outlook from $245M-$255M to $247M-$255M vs $250M Est.,2016-05-02 16:34:00-04:00,LMNX,negative
770065.0,"Luminex Reports Q1 Adj. EPS $0.29 vs $0.14 Est., Sales $63M vs $61M Est.",2016-05-02 16:33:00-04:00,LMNX,neutral
770066.0,Luminex Gets FDA Approval And CE Mark For SYNCT Software,2016-04-14 09:48:00-04:00,LMNX,positive
770067.0,"Luminex Corp. Receives FDA Clearance, CE Mark For SYNCT Software",2016-04-14 08:31:00-04:00,LMNX,neutral
770068.0,"Luminex Receives CE-IVD Mark for ARIES System, ARIES HSV 1&2 Assay",2016-03-21 04:16:00-04:00,LMNX,neutral
770069.0,Luminex Announces Collaboration With University Of Sao Paulo To Validate Zika Virus Detection Panel,2016-02-26 10:19:00-05:00,LMNX,positive
770070.0,Luminex Reports Collaboration with University of Sao Paulo for Validation of Zika Virus Detection Panel,2016-02-25 17:17:00-05:00,LMNX,neutral
770071.0,"Luminex Announces Received Medical Device License for ARIES System, ARIES HSV 1&2 Assay in Canada",2016-02-22 16:35:00-05:00,LMNX,neutral
770072.0,"Luminex Sees FY16 Rev. $245-$255M s. Est. $249M, Q1 Rev. $60-$62M vs. Est. $61.93M",2016-02-01 16:07:00-05:00,LMNX,neutral
770073.0,"Luminex Reports Q4 EPS $0.56 vs. Est. $0.15, Rev. $60.4M vs. Est. $60.21M",2016-02-01 16:06:00-05:00,LMNX,neutral
770074.0,Luminex Corporation Receives FDA Clearance for NxTAG® Respiratory Pathogen Panel,2015-12-18 08:30:00-05:00,LMNX,neutral
770075.0,Stocks Hitting 52-Week Highs,2015-12-16 10:06:00-05:00,LMNX,neutral
770076.0,"Luminex Reports Q3 Adj. EPS $0.22 vs $0.11 Est., Sales $60.6M vs $57.2M Est.; Raises FY15 Sales Guidance from $232M-$236M to $235M-$238M vs $234.7M Est.",2015-11-02 16:23:00-05:00,LMNX,neutral
770077.0,Luminex Corporation and Bio-Techne Corporation Extend and Expand Partnership,2015-10-20 08:32:00-04:00,LMNX,positive
770078.0,Luminex Corporation Given CE-IVD Mark for NxTAG Respiratory Pathogen Panel,2015-10-19 08:09:00-04:00,LMNX,neutral
770079.0,"US Stock Futures Surge; Goldman Sachs, Citigroup Earnings In Focus",2015-10-15 07:42:00-04:00,LMNX,neutral
770080.0,"Affymetrix, Luminex Announce Distribution Agreement for Multiplexed Assay Instrument Platform",2015-10-15 06:31:00-04:00,LMNX,positive
770081.0,Luminex Corporation Receives FDA Clearance for ARIES® System and ARIES® HSV 1&2 Assay,2015-10-07 06:30:00-04:00,LMNX,neutral
770082.0,Benzinga's Volume Movers,2015-08-04 10:26:00-04:00,LMNX,neutral
770083.0,"Wedbush Analyst Upgrades Luminex After Quarterly Results, New CEO",2015-08-04 08:56:00-04:00,LMNX,neutral
770084.0,"Wedbush Upgrades Luminex to Outperform, Maintains $22.00 PT",2015-08-04 06:52:00-04:00,LMNX,neutral
770085.0,Luminex Sees Q3 Sales $56M-$58M; FY15 Sales $232M-$236M,2015-08-03 16:13:00-04:00,LMNX,neutral
770086.0,"Luminex Reports Q2 Adj EPS $0.27, no estimate",2015-08-03 16:13:00-04:00,LMNX,negative
770087.0,Luminex Corporation Gives FDA 510 Submissions for ARIES System and ARIES HSV 1&2 Assay,2015-07-14 16:06:00-04:00,LMNX,neutral
770088.0,Top 4 NASDAQ Stocks In The Medical Instruments & Supplies Industry With The Highest Profit Margin,2015-07-10 04:44:00-04:00,LMNX,positive
770089.0,Enzo Biochem Settles On Patent Infringement Action Fro $7.1M,2015-07-06 10:00:00-04:00,LMNX,negative
770090.0,UPDATE: Lumenis Announces Will Be Purchased by XIO Group for $14/Share in Cash,2015-06-18 06:01:00-04:00,LMNX,neutral
770091.0,Hearing Luminex Has Named Jonathan Clark as Pres,2015-06-16 08:04:00-04:00,LMNX,neutral
770092.0,Luminex Corporation Begins Clinical Trials for ARIES GBS Assay,2015-06-08 16:17:00-04:00,LMNX,neutral
770093.0,"Luminex Reports Commencement of Clinical, Analytical Trials for ARIES GBS Assay",2015-06-08 16:09:00-04:00,LMNX,neutral
770094.0,"Luminex Reports Q1 Adj. EPS $0.23 vs $0.12 Est., Sales $57.7M vs $56.5M Est.",2015-05-04 16:22:00-04:00,LMNX,neutral
770095.0,"Luminex Reports Q1 EPS $0.23 vs. Est. $0.12, Rev. $57.7M vs. Est. $56.51M; Earnings May Not Compare",2015-05-04 16:08:00-04:00,LMNX,neutral
770096.0,A New Test to Simultaneously Detect 22 Respiratory Pathogens,2015-04-06 16:05:00-04:00,LMNX,neutral
770097.0,Luminex Corporation Starts Clinical Trials for ARIES System and ARIES HSV 1&2 Assay,2015-03-30 16:06:00-04:00,LMNX,neutral
770098.0,Mid-Morning Market Update: Markets Open Higher; AutoNation Profit Beats Views,2015-02-03 10:55:00-05:00,LMNX,positive
770099.0,Stocks Hitting 52-Week Lows,2015-02-03 10:28:00-05:00,LMNX,negative
770100.0,Morning Market Losers,2015-02-03 09:58:00-05:00,LMNX,negative
770101.0,"Luminex Corporation Reports Q4 EPS $0.19 Vs Est. 0.12, Revs $85.1M Vs Est. $58.31M",2015-02-02 16:07:00-05:00,LMNX,neutral
770102.0,"Earnings Scheduled For February 2, 2015",2015-02-02 04:57:00-05:00,LMNX,neutral
770103.0,"Leerink Swann Downgrades Luminex Corporation to Market Perform, Lowers PT to $22.00",2014-11-07 06:37:00-05:00,LMNX,negative
770104.0,Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline,2014-10-28 13:50:00-04:00,LMNX,positive
770105.0,Mid-Morning Market Update: Markets Open Higher; Pfizer Profit Tops Street View,2014-10-28 11:06:00-04:00,LMNX,positive
770106.0,Morning Market Losers ,2014-10-28 09:58:00-04:00,LMNX,negative
770107.0,Luminex Corporation Sees FY2014 Sales $225.0M-228.0M,2014-10-27 16:35:00-04:00,LMNX,neutral
770108.0,Luminex Corporation Reports Q3 EPS of $0.27 vs $0.10 Est; Revenue of $56.70M vs $56.55M Est,2014-10-27 16:08:00-04:00,LMNX,neutral
770109.0,Luminex Corporation Announces Retirement of CEO Patrick Balthrop; Appoints Nachum Shamir As Pres. & CEO,2014-10-15 08:52:00-04:00,LMNX,neutral
770110.0,"Cowen & Company Upgrades Luminex Corporation to Market Perform, Raises PT to $18.00",2014-10-09 09:19:00-04:00,LMNX,neutral
770111.0,"Luminex Reports FDA Clearance for Added New Clinical Targets, Sample Type for Use with xTAG Panel",2014-09-29 16:05:00-04:00,LMNX,neutral
770112.0,Luminex Corporation Reports Q2 EPS of $0.11 vs $0.10 Est; Revenue of $55.60M vs $55.91M Est,2014-07-28 16:06:00-04:00,LMNX,neutral
770113.0,Luminex Announces European Launch of New Sample-to-Answer System at ECCMID,2014-05-05 05:42:00-04:00,LMNX,neutral
770114.0,Morning Market Movers ,2014-04-29 09:43:00-04:00,LMNX,neutral
770115.0,Luminex Corporation Reports Q1 EPS of $0.24 vs $0.12 Est; Revenue of $56.60M vs $55.31M Est,2014-04-28 16:05:00-04:00,LMNX,neutral
770116.0,Luminex Corporation Sees FY2014 Sales $225.0M-240.0M vs $234.40M Est,2014-02-03 16:20:00-05:00,LMNX,neutral
770117.0,Luminex Corporation Reports Q4 EPS of $0.21 vs $0.07 Est; Revenue of $55.20M vs $56.63M Est,2014-02-03 16:20:00-05:00,LMNX,neutral
770118.0,Luminex Corporation Sees FY2013 Sales $212.0M-217.0M vs $221.67M Est,2013-11-04 16:50:00-05:00,LMNX,neutral
770119.0,Luminex Corporation Reports Q3 EPS of $0.06 vs $0.11 Est; Revenue of $50.80M vs $54.67M Est,2013-11-04 16:49:00-05:00,LMNX,neutral
770120.0,"Luminex Wins FDA, European Claearnce for xTAG CYP2C19 Kit",2013-09-23 16:12:00-04:00,LMNX,positive
770121.0,"Luminex Corporation Receives FDA and European Clearance for a New Personalized Medicine Genotyping Assay, xTAG CYP2C19 Kit",2013-09-23 16:06:00-04:00,LMNX,neutral
770122.0,"Market Wrap for Tuesday, July 30: Technology Sector Rises; Basic Materials Hit Hard",2013-07-30 16:20:00-04:00,LMNX,negative
770123.0,UBS Downgrades Luminex Corporation to Neutral,2013-07-30 09:28:00-04:00,LMNX,neutral
770124.0,Luminex Corporation Reports Q2 EPS of $0.17 vs $0.10 Est; Revenue of $54.30M vs $54.16M Est,2013-07-29 16:08:00-04:00,LMNX,neutral
770125.0,"Luminex Corporation Receives FDA and European Clearance for an Updated Version of Its Comprehensive Genotyping Assay, xTAG® CYP2D6 Kit",2013-07-15 16:05:00-04:00,LMNX,positive
770126.0,"Luminex Wins FDA, European Clearance for Updated Version of XTAG CYP2D6 Kit",2013-07-15 16:05:00-04:00,LMNX,positive
770127.0,Hearing Cowen Says Sell Strength in Luminex,2013-06-11 14:01:00-04:00,LMNX,positive
770128.0,Afternoon Market Losers,2013-06-11 13:24:00-04:00,LMNX,negative
770129.0,"Jefferies Maintains Hold on Luminex Corporation, Raises PT to $20.00",2013-05-31 11:20:00-04:00,LMNX,neutral
770130.0,UPDATE: Jefferies Assumes Coverage on Luminex at Hold on Long-Term Caution,2013-05-31 11:20:00-04:00,LMNX,neutral
770131.0,Illumina and Other Bargain Biotech Stocks Worth a Look Now,2013-05-01 12:57:00-04:00,LMNX,positive
770132.0,Luminex Corporation Reports Q1 EPS of $0.19 vs $0.07 Est; Revenue of $53.20M vs $51.94M Est,2013-04-29 16:07:00-04:00,LMNX,neutral
770133.0,Luminex Corporation Receives U.S. FDA Clearance for MAGPIX® Instrument with Novel xTAG® Gastrointestinal Pathogen Panel,2013-04-15 08:32:00-04:00,LMNX,positive
770134.0,"UPDATE: Wedbush Initiates Luminex at Neutral, Top Line Growth Expected to Continue",2013-03-26 09:10:00-04:00,LMNX,positive
770135.0,Benzinga's Top Initiations,2013-03-26 07:29:00-04:00,LMNX,positive
770136.0,"Wedbush Initiates Coverage on Luminex Corporation at Neutral, Announces $17.00 PT",2013-03-25 16:29:00-04:00,LMNX,neutral
770137.0,"Wedbush Initiates Coverage on Luminex Corporation at Neutral, Announces $17.00 PT",2013-03-25 16:25:00-04:00,LMNX,neutral
770138.0,Luminex Announces 900K Share Buyback Plan,2013-02-22 10:04:00-05:00,LMNX,positive
770139.0,Luminex Corporation Sees FY2013 Sales $220.0M-230.0M vs $227.40M Est,2013-02-04 16:08:00-05:00,LMNX,neutral
770140.0,Luminex Corporation Reports Q4 EPS of $0.10 vs $0.09 Est; Revenue of $55.50M vs $54.04M Est,2013-02-04 16:07:00-05:00,LMNX,neutral
770141.0,Luminex Shares to Resume Trading at 9AM EST,2013-01-15 08:54:00-05:00,LMNX,positive
770142.0,Luminex Wins FDA Clearance for Xtag Gastro Pathogen Paenl,2013-01-15 08:33:00-05:00,LMNX,positive
770143.0,Luminex Halted News Pending,2013-01-15 08:26:00-05:00,LMNX,neutral
770144.0,Luminex Halted News Pending,2013-01-15 08:26:00-05:00,LMNX,neutral
770145.0,Cowen & Company Downgrades Luminex Corporation to Underperform,2013-01-14 08:31:00-05:00,LMNX,neutral
770146.0,Luminex Reports Q3 EPS $0.04 vs $0.06 Est; Revenues $50M vs $51.26M Est,2012-10-29 16:05:00-04:00,LMNX,neutral
770147.0,"UBS Upgrades Luminex from Neutral to Buy, Lowers PT from $25 to $22",2012-08-23 11:03:00-04:00,LMNX,negative
770148.0,UBS Upgrades Luminex from Neutral to Buy,2012-08-23 08:14:00-04:00,LMNX,neutral
770149.0,Benzinga's Top Upgrades,2012-07-31 07:16:00-04:00,LMNX,positive
770150.0,William Blair Downgrades Luminex from Outperform to Market Perform,2012-07-31 06:47:00-04:00,LMNX,neutral
770151.0,Luminex Reports Q2 EPS $0.07 vs $0.08 Est; Revenues $48.3M vs $49.22M Est,2012-07-30 16:14:00-04:00,LMNX,neutral
770152.0,Leerink Swann Upgrades Luminex from Market Perform to Outperform,2012-07-23 06:52:00-04:00,LMNX,neutral
770153.0,UPDATE: JP Morgan Upgrades Luminex to Neutral Following Sharp Selloff in Shares  ,2012-07-16 12:48:00-04:00,LMNX,positive
770154.0,"JP Morgan Upgrades Luminex from Underweight to Neutral, Maintains PT at $17",2012-07-16 06:06:00-04:00,LMNX,positive
770155.0,"Jefferies & Company Maintains Luminex at Hold, Lowers PT from $18 to $17",2012-07-10 09:09:00-04:00,LMNX,negative
770156.0,"Piper Jaffray Maintains Luminex at Underweight, Lowers PT from $21 to $18",2012-07-09 15:03:00-04:00,LMNX,negative
770157.0,Luminex Drops 17% on $50M Acquisition of GenturaDx,2012-07-09 13:49:00-04:00,LMNX,neutral
770158.0,UPDATE: JP Morgan Reduces PT to $17 on Luminex; Gentura Acquisition Detracts From Core Focus  ,2012-07-09 13:24:00-04:00,LMNX,positive
770159.0,"JP Morgan Maintains Luminex at Underweight, Lowers PT from $18 to $17",2012-07-09 11:58:00-04:00,LMNX,positive
770160.0,Luminex Corporation Announces Agreement to Acquire GenturaDx ,2012-07-09 08:45:00-04:00,LMNX,positive
770161.0,Luminex Will Replace PF Chang's in S&P Smallcap 600,2012-06-07 17:18:00-04:00,LMNX,neutral
770162.0,"UBS Maintains Luminex at Neutral, Raises PT from $22 to $25",2012-05-01 11:35:00-04:00,LMNX,neutral
770163.0,"Piper Jaffray Maintains Luminex at Underweight, Raises PT from $19 to $21",2012-05-01 07:34:00-04:00,LMNX,neutral
770164.0,Luminex Reports Q1 EPS $0.08 vs $0.08 Est; Revenues $48.7M vs $48.23M Est,2012-04-30 16:06:00-04:00,LMNX,neutral
770165.0,Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform  ,2012-04-26 16:07:00-04:00,LMNX,neutral
770166.0,"Morning Social Media Outlook for Wednesday April 4 (CELG, LMNX, SNDK, LTD)",2012-04-04 10:47:00-04:00,LMNX,neutral
770167.0,Bio-Rad Laboratories up 12.7% After Announcing Agreement with Luminex ,2012-04-03 10:39:00-04:00,LMNX,positive
770168.0,Piper Jaffray Remains Underweight on Luminex Shares,2012-02-07 09:02:00-05:00,LMNX,positive
770169.0,Luminex Reports Q4 EPS $0.11 vs $0.07 Est; Revenues $47.9M vs $46.79M Est	 			,2012-02-06 16:06:00-05:00,LMNX,neutral
770170.0,UPDATE: JP Morgan Downgrades Luminex to Underweight,2012-01-04 10:42:00-05:00,LMNX,positive
770171.0,JP Morgan Downgrades Luminex to Underweight,2012-01-04 06:50:00-05:00,LMNX,positive
770172.0,Cooper Companies Earnings Preview: Double-Digit Revenue Growth Expected,2011-12-07 07:03:00-05:00,LMNX,positive
770173.0,Disclosure Insight Maintains Medium Risk Rating on Luminex ,2011-11-29 06:51:00-05:00,LMNX,negative
770174.0,J.P. Morgan Maintains Neutral on Luminex,2011-11-02 07:46:00-04:00,LMNX,neutral
770175.0,Luminex Corp Reports Q3 EPS $0.05 May Not be Comparable to $0.06 Est; Revenues $45.6M vs $43.31M Est,2011-11-01 16:27:00-04:00,LMNX,neutral
770176.0,"Tuesday's Top Gainers on NASDAQ: FairPoint, MAKO Surgical, Luminex, Syntroleum",2011-08-10 11:16:00-04:00,LMNX,positive
770177.0,Intraday Gainers; Luminex up Over 25% ,2011-08-09 15:08:00-04:00,LMNX,neutral
770178.0,UPDATE: Jefferies Raising Price Target On Luminex Corp ,2011-08-09 07:29:00-04:00,LMNX,neutral
770179.0,"UPDATES: Piper Jaffray Reiterates Underweight on Luminex, Raises PT to $19",2011-08-09 07:15:00-04:00,LMNX,neutral
770180.0,Jefferies Raises PT On Luminex To $18,2011-08-09 07:00:00-04:00,LMNX,neutral
770181.0,Piper Jaffray Raises PT On Luminex To $19,2011-08-09 06:20:00-04:00,LMNX,neutral
770182.0,Limunex Reports Q2 EPS $0.11 vs $0.06 Est; Revenues $47.6M vs $40.67M Est            ,2011-08-08 16:12:00-04:00,LMNX,neutral
770183.0,"Luminex Corporation Receives FDA Clearance for New, Front Line Respiratory Viral Panel Test  ",2011-07-19 16:07:00-04:00,LMNX,neutral
770184.0,"UPDATE: Luminex Sees Deal Hurting GAAP EPS for 2011, Adding in 2012   ",2011-06-21 16:11:00-04:00,LMNX,negative
770185.0,Luminex Corporation to Acquire EraGen Biosciences for $34M,2011-06-21 16:05:00-04:00,LMNX,neutral
770186.0,"NASDAQ Stocks Hitting 52-Week Highs (TISA, LMNX, GCOM, ASMI)",2011-05-11 10:07:00-04:00,LMNX,neutral
770187.0,UPDATE: J.P. Morgan Raising Price Target On Luminex  (LMNX),2011-05-10 08:00:00-04:00,LMNX,neutral
770188.0,Jefferies Raises PT On LMNX To $17,2011-05-10 07:14:00-04:00,LMNX,neutral
770189.0,Jefferies Lowers PT On Luminex To $16,2011-05-10 06:10:00-04:00,LMNX,negative
770190.0,"Reports EPS of $0.11, May Not Be Comparable to $0.06 Estimate; Revenues $43.28M vs. $39.90M Estimate",2011-05-09 15:04:00-04:00,LMNX,neutral
770191.0,Luminex and Partners HealthCare Announce Collaboration Agreement ,2011-02-15 09:31:00-05:00,LMNX,positive
770192.0,Luminex Corporation Reports Q4 EPS of $.06 vs. $.05,2011-02-07 16:16:00-05:00,LMNX,neutral
770193.0,"Luminex, One Lambda Renew Tie - Analyst Blog",2010-12-08 17:00:00-05:00,LMNX,neutral
770194.0,"Luminex, One Lambda Renew Tie - Analyst Blog",2010-12-08 16:41:00-05:00,LMNX,neutral
770195.0,Luminex and One Lambda Renew 10-Year Strategic Partnership,2010-12-07 16:36:00-05:00,LMNX,neutral
770196.0,New Diagnostic Test from Luminex - Analyst Blog,2010-11-18 12:33:00-05:00,LMNX,neutral
770197.0,New Diagnostic Test from Luminex - Analyst Blog,2010-11-18 07:10:00-05:00,LMNX,neutral
770198.0,Luminex Corporation Authorizes Repurchase Plan of 1M Shares,2010-11-17 16:11:00-05:00,LMNX,positive
770199.0,Luminex Corporation Launches New FDA Cleared Test ,2010-11-17 09:46:00-05:00,LMNX,positive
770200.0,Luminex Downgraded to Underperform - Analyst Blog,2010-11-15 18:03:00-05:00,LMNX,neutral
770201.0,Luminex Misses on All Fronts - Analyst Blog,2010-11-08 13:03:00-05:00,LMNX,negative
770202.0,Luminex Reports Mixed 3Q,2010-11-05 08:08:00-04:00,LMNX,neutral
770203.0,Luminex Corporation Reports Third Quarter EPS of $(0.02),2010-11-04 16:35:00-04:00,LMNX,neutral
770204.0,Good News for Luminex MAGPIX - Analyst Blog,2010-09-09 11:39:00-04:00,LMNX,positive
770205.0,Luminex's New Cystic Fibrosis Test - Analyst Blog,2010-08-27 12:54:00-04:00,LMNX,neutral
770206.0,Luminex Reiterated at Neutral - Analyst Blog,2010-08-11 16:06:00-04:00,LMNX,neutral
770207.0,"Luminex Misses, Reaffirms View - Analyst Blog",2010-08-08 06:32:00-04:00,LMNX,negative
770208.0,Jefferies Global Life Sciences Conference Takeaways; Diagnostics,2010-06-14 11:28:00-04:00,LMNX,neutral
770209.0,Stephens Upgrades LMNX To Overweight,2010-05-24 06:23:00-04:00,LMNX,negative
770210.0,"Benzinga’s Volume Movers (CRUS, FOSL, ZOLT, LMNX)",2010-05-11 14:03:00-04:00,LMNX,neutral
770211.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,LMNX,positive
770212.0,Luminex Beats Street Expectations (LMNX),2010-01-12 08:01:00-05:00,LMNX,neutral
